Pfizer Obesity Deal History & Licensing Activity
Pfizer Obesity is a large pharma headquartered in US. Over the past three years, Pfizer Obesity has been involved in 6 licensing and acquisition transactions, with a primary focus on Vaccines (3 deals).
Deals (12mo)
3
Active Trials
10
Top Modality
Vaccines
Focus Area
Infectious Disease
Pfizer Obesity Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Pfizer Obesity in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Matrix-M | Pfizer | Other | Unknown | license | Apr 2026 |
| RSV vaccine | Pfizer | Vaccines | Unknown | license | Jul 2025 |
Pfizer Obesity Pipeline Focus
Therapeutic areas and modalities where Pfizer Obesity is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Pfizer Obesity Strategic Signals
Key indicators of Pfizer Obesity's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
See How Your Asset Matches Pfizer Obesity's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Rare Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for rare disease
Vaccines Benchmarks
Upfront, milestone, and royalty benchmarks for vaccines deals
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
About Pfizer Obesity Licensing & Deal Activity
Pfizer Obesity is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 6 deals over the past three years, Pfizer Obesity ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Pfizer Obesity include Infectious Disease (3 deals and trials), Other (2 deals and trials), Rare Disease (2 deals and trials), and Gastroenterology (1 deal and trial). In terms of modality, Pfizer Obesity has shown particular interest in vaccines, other, gene therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Pfizer Obesity and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Pfizer Obesity's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.